New gel aims to soothe painful rash from cancer drugs
Symptom relief
Recruiting now
This study is testing a gel called HT-001 to see if it can safely treat skin problems like rashes, severe dryness, and nail infections that are common side effects of a specific type of cancer drug (EGFR inhibitors). About 152 adult cancer patients who develop these skin issues w…
Phase: PHASE2 • Sponsor: Hoth Therapeutics, Inc. • Aim: Symptom relief
Last updated Apr 03, 2026 14:41 UTC